Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Corvus Pharmaceuticals Inc’s stock clocked out at $5.01, up 5.92% from its previous closing price of $4.73. In other words, the price has increased by $5.92 from its previous closing price. On the day, 0.72 million shares were traded. CRVS stock price reached its highest trading level at $5.12 during the session, while it also had its lowest trading level at $4.66.
Ratios:
To gain a deeper understanding of CRVS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.92 and its Current Ratio is at 0.92. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 02, 2025, initiated with a Buy rating and assigned the stock a target price of $11.
On August 18, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 06 ’24 when Jones William Benton bought 20,000 shares for $1.73 per share. The transaction valued at 34,624 led to the insider holds 153,773 shares of the business.
MILLER RICHARD A MD bought 577,634 shares of CRVS for $1,000,000 on May 06 ’24. The President and CEO now owns 577,634 shares after completing the transaction at $1.73 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRVS now has a Market Capitalization of 321929088 and an Enterprise Value of 508283872.
Stock Price History:
The Beta on a monthly basis for CRVS is 1.07, which has changed by 1.4439025 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, CRVS has reached a high of $10.00, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is -30.11%, while the 200-Day Moving Average is calculated to be 13.84%.
Shares Statistics:
It appears that CRVS traded 1.16M shares on average per day over the past three months and 659980 shares per day over the past ten days. A total of 62.58M shares are outstanding, with a floating share count of 50.33M. Insiders hold about 21.68% of the company’s shares, while institutions hold 28.60% stake in the company. Shares short for CRVS as of 1730332800 were 2925030 with a Short Ratio of 4.67, compared to 1727654400 on 2149980. Therefore, it implies a Short% of Shares Outstanding of 2925030 and a Short% of Float of 5.8000002.
